Hu LX - Search Results

1

N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer.

Wang YM, Hu LX, Liu ZM, You XF, Zhang SH, Qu JR, Li ZR, Li Y, Kong WJ, He HW, Shao RG, Zhang LR, Peng ZG, Boykin DW, Jiang JD. Wang YM, et al. Among authors: hu lx. Clin Cancer Res. 2008 Oct 1;14(19):6218-27. doi: 10.1158/1078-0432.CCR-08-0550. Clin Cancer Res. 2008. PMID: 18829501

2

Synthesis and structure-activity relationships of carbazole sulfonamides as a novel class of antimitotic agents against solid tumors.

Hu L, Li ZR, Li Y, Qu J, Ling YH, Jiang JD, Boykin DW. Hu L, et al. J Med Chem. 2006 Oct 19;49(21):6273-82. doi: 10.1021/jm060546h. J Med Chem. 2006. PMID: 17034133

3

Novel pyridinyl and pyrimidinylcarbazole sulfonamides as antiproliferative agents.

Hu L, Li ZR, Wang YM, Wu Y, Jiang JD, Boykin DW. Hu L, et al. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1193-6. doi: 10.1016/j.bmcl.2006.12.034. Epub 2006 Dec 15. Bioorg Med Chem Lett. 2007. PMID: 17197178

4

Novel potent antimitotic heterocyclic ketones: synthesis, antiproliferative activity, and structure-activity relationships.

Hu L, Jiang JD, Qu J, Li Y, Jin J, Li ZR, Boykin DW. Hu L, et al. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3613-7. doi: 10.1016/j.bmcl.2007.04.048. Epub 2007 Apr 25. Bioorg Med Chem Lett. 2007. PMID: 17482458

5

3-(2'-Bromopropionylamino)-benzamides as novel S-phase arrest agents.

Hu L, Li ZR, Li JN, Qu J, Jiang JD, Boykin DW. Hu L, et al. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6847-52. doi: 10.1016/j.bmcl.2007.10.016. Epub 2007 Oct 17. Bioorg Med Chem Lett. 2007. PMID: 17977727

6

Azaterphenyl diamidines as antileishmanial agents.

Hu L, Arafa RK, Ismail MA, Wenzler T, Brun R, Munde M, Wilson WD, Nzimiro S, Samyesudhas S, Werbovetz KA, Boykin DW. Hu L, et al. Bioorg Med Chem Lett. 2008 Jan 1;18(1):247-51. doi: 10.1016/j.bmcl.2007.10.091. Epub 2007 Oct 30. Bioorg Med Chem Lett. 2008. PMID: 18006310

7

Novel diaryl or heterocyclic sulfonamides as antimitotic agents.

Hu L, Li ZR, Jiang JD, Boykin DW. Hu L, et al. Anticancer Agents Med Chem. 2008 Oct;8(7):739-45. doi: 10.2174/187152008785914806. Anticancer Agents Med Chem. 2008. PMID: 18855576 Review.

8

Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.

Hu L, Kully ML, Boykin DW, Abood N. Hu L, et al. Bioorg Med Chem Lett. 2009 Mar 1;19(5):1292-5. doi: 10.1016/j.bmcl.2009.01.075. Epub 2009 Feb 7. Bioorg Med Chem Lett. 2009. PMID: 19208475

9

Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.

Hu L, Kully ML, Boykin DW, Abood N. Hu L, et al. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3374-7. doi: 10.1016/j.bmcl.2009.05.061. Epub 2009 May 20. Bioorg Med Chem Lett. 2009. PMID: 19481935

10

Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.

Hu L, Kully ML, Boykin DW, Abood N. Hu L, et al. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4626-9. doi: 10.1016/j.bmcl.2009.06.077. Epub 2009 Jun 25. Bioorg Med Chem Lett. 2009. PMID: 19589676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters